Xarelto Lawsuit – Do you have a case?
Xarelto® Poses a Risk of Irreversible Internal Bleeding
Have you or a loved one suffered from internal bleeding after using Xarelto? Contact us today for a free and confidential case evaluation.
Xarelto® is an Anticoagulant
Xarelto (rivaroxaban) is a prescription oral anticoagulant otherwise known as a blood thinner. Xarelto was created jointly by Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals. It is marketed as safer and easier alternative to other anticoagulant medications. First approved by the FDA in July of 2011, Xarelto is prescribed by doctors to reduce the risk of blood clots or stroke. More specifically, it is used to prevent deep vein thrombosis or pulmonary embolism in patients whom have undergone knee or hip replacement surgery, or to reduce the stroke risk in patients with atrial fibrillation, an irregular heartbeat.
The makers of Xarelto have also applied with the FDA to approve the use of Xarelto for more treatments such as being prescribed to reduce the risk of heart attacks in patients with acute artery disease, but the FDA has denied Xarelto’s approval for such uses.
Xarelto works to stop the clotting process by inhibiting a protein called factor Xa, which is a protein involved in the process of coagulation, this in turn prevents the protein thrombin from forming. While most blood thinners require specific dosing for each individual user, Xarelto is prescribed in one uniform dose. Like most blood thinners, the usage of Xarelto comes with a risk of internal bleeding.
Xarelto® Usage Comes With Serious Risks
While previous blood thinner medications required regular doctor visits and alterations to a person’s lifestyle and dietary habits, Xarelto is sold and marketed as an alternative which does not require the constant check-ups and the drastic lifestyle changes. These intended benefits do not come without certain risks though. Xarelto like many blood thinners can cause serious internal bleeding, but unlike other blood thinners Xarelto does not have an antidote for emergency situations. The lack of an antidote can cause the bleeding to become uncontrolled, and the manufacturers of Xarelto have yet to provide doctors with information on how to combat such a situation.
A double-blind ROCKET AF study coordinated by the Duke Clinical Research Institute and published in the New England Journal of Medicine compared Xarelto to warfarin. The study which included over 1400 patients concluded that while the effectiveness of the two drugs were similar, the instances of gastrointestinal bleeding and internal bleeding which required transfusion were more frequent with Xarelto.
The risks associated with Xarelto are numerous, but the most severe are those associated with internal bleeding. Side effects such as brain hemorrhage, gastrointestinal bleeding, kidney bleeding and fatal bleeding events can occur on Xarelto. There is also evidence that patients on Xarelto whom have spinal injections or epidurals are at a higher risk of forming blood clots in the spine which can lead to paralysis.
Lawsuits against The Makers of Xarelto®
There have been numerous lawsuits filed by people who have taken Xarelto and suffered from severe bleeding events, as well as lawsuits filed by the families of people whose bleeding events proved fatal. These lawsuits allege that the makers of Xarelto, Johnson & Johnson and Bayer, have failed to adequately warn about the dangers of irreversible bleeding and have misrepresented that safety and effectiveness of the drug. Many claims filed have also called for the recall of Xarelto alleging without an effective antidote to the bleeding it can cause, the drug is unreasonably dangerous and defective.
Due to number of lawsuits that have been filed across the United States, a coordinated proceeding was set up by a panel of federal judges. In December of 2014 an order was issued establishing a Xarelto MDL (multidistrict litigation) in the U.S. District Court for the Eastern District of Louisiana.
A similar batch of litigations against another drug in the $10 billion dollar anticoagulant market has recently yielded significant settlements. Thousands of lawsuits were filed against Boehringer Ingelheim alleging their failure to warn about serious bleeding problems associated with their blood thinner Pradaxa®. Boerhringer Ingelheim agreed to pay $650 million dollars to settle roughly 4,000 claims.
If you or a loved one have suffered from a traumatic bleeding event after using Xarelto, you may be entitled to compensation. Contact us today, before it is too late!
Sanders Phillips Grossman Advocates For the Consumer
Sanders Phillips Grossman is a joint venture between two of the nation’s top mass tort firms in Phillips Law Firm and Sanders Viener Grossman. We represent people who have been harmed by defective drugs and medical devices throughout the United States and Puerto Rico. Our outstanding attorneys have years of experience fighting against the greed of America’s drug and medical device companies.
The companies we fight against are some of the largest, wealthiest and most influential entities in the world. Here at Sanders Phillips Grossman we have the type of experienced and savvy attorneys to handle a claim against these companies. Our history in dealing with these types of claims has allowed us to take leadership roles in many of the national defective drug and device litigations.
When your life has been harmed by the side effects of a defective drug or medical device, the team at Sanders Phillips Grossman is here to help. Contact us anytime day or night for a free case evaluation.
What will an attorney cost me?
We represent our clients on a contingency fee basis. This means that if we do not win your claim their will be no obligation for you to pay us. The only way we are compensated for our services is if we are successful on your claim. A successful outcome on your claim could entitle you to damages for medical expenses, wage loss, pain and suffering, loss of enjoyment of life and loss of consortium. We would love to discuss your options further. Contact us today for a free consultation.
Do I have a case?
Sanders Phillips Grossman is currently accepting cases for people who have used Xarelto to and suffered from a significant bleeding event. If you or a loved one were prescribed Xarelto to reduce the risk of blood clots or stroke and subsequently were hospitalized for:
- Brain hemorrhage
- Internal bleeding
- Gastrointestinal bleeding
- Kidney bleeding
- Death from bleeding out
We would like to discuss your legal options with you. Contact us today.
You can reach us by telephone, by email, by text message or by filling out the contact form to your right. We have representatives standing by twenty-four hours a day seven days a week waiting to hear your story. Contact us now, you could be entitled to compensation, but must act quickly!